Stephen D Smith
Overview
Explore the profile of Stephen D Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
1927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samples L, Sadrzadeh H, Frigault M, Jacobson C, Hamadani M, Gurumurthi A, et al.
Blood
. 2025 Feb;
PMID: 39938007
Burkitt lymphoma (BL) is an aggressive B-cell lymphoma associated with poor outcomes in patients with relapsed/refractory disease. This multicenter, retrospective study evaluated real-world CD19 CAR T-cell therapy outcomes in patients...
2.
Ho C, Zhu S, Gooley T, Gujral T, Lynch R, Poh C, et al.
EJHaem
. 2024 Dec;
5(6):1173-1181.
PMID: 39691260
Background: The tumor microenvironment (TME), including infiltrating T-cells, is thought to play a major role in the pathogenesis and prognosis of follicular lymphoma (FL) and may contribute to its widely...
3.
Hostler T, Poerio G, Nader C, Mank S, Lin A, Villena-Gonzalez M, et al.
Multisens Res
. 2024 Dec;
37(6-8):499-528.
PMID: 39658576
Autonomous Sensory Meridian Response (ASMR) is a multisensory experience most often associated with feelings of relaxation and altered consciousness, elicited by stimuli which include whispering, repetitive movements, and close personal...
4.
Huang I, Baek G, Cohen J, Khajaviyan S, Louie S, Samples L, et al.
JCO Oncol Pract
. 2024 Nov;
:OP2400416.
PMID: 39556786
Purpose: Venetoclax is the standard of care for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) but requires intensive monitoring for optimal safety. Clinical relevance of intensive monitoring in practice is...
5.
Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, et al.
Haematologica
. 2024 Nov;
110(3):706-714.
PMID: 39540227
Outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) are poor. Loncastuximab- teserine (Lonca) is an antibody-drug conjugate which was approved by the Food and Drug Administration for...
6.
Phillips T, Wang M, Robak T, Gallinson D, Stevens D, Patel K, et al.
Haematologica
. 2024 Sep;
110(3):715-724.
PMID: 39234862
This multicenter, open-label, phase Ib study (ACE-LY-106) assessed the safety and efficacy of acalabrutinib, bendamustine, and rituximab (ABR) in treatment-naïve (TN) and relapsed or refractory (R/R) mantle cell lymphoma (MCL)....
7.
Epperla N, Zayac A, Landsburg D, Bock A, Nowakowski G, Ayers E, et al.
Blood Adv
. 2024 Aug;
8(20):5355-5364.
PMID: 39189932
Little is known about the central nervous system (CNS) risk in high-grade B-cell lymphoma, not otherwise specified (HGBL NOS). Hence, we sought to describe the rates of baseline CNS involvement,...
8.
Wang M, Robak T, Maddocks K, Phillips T, Smith S, Gallinson D, et al.
Blood Adv
. 2024 May;
8(17):4539-4548.
PMID: 38781315
This phase 1b study evaluated safety and efficacy of acalabrutinib, venetoclax, and rituximab (AVR) in treatment-naive mantle cell lymphoma (TN MCL). Patients received acalabrutinib from cycle 1 until progressive disease...
9.
Jakobson L, McQuarrie A, Van Landeghem C, Smith S
Front Psychol
. 2024 Mar;
15:1354120.
PMID: 38533217
Introduction: Alexithymia is characterized by difficulties identifying and describing feelings but expression of externally oriented thinking (EOT) and difficulty fantasizing is more variable. In two studies, we investigated whether links...
10.
MacKay C, Desroches A, Smith S
Cogn Neurosci
. 2024 Feb;
15(1):1-11.
PMID: 38362596
Previous research has suggested that the perception of emotional images may also activate brain regions related to the preparation of motoric plans. However, little research has investigated whether these emotion-movement...